NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,170 filers reported holding NOVARTIS A G in Q4 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $311,517 | +0.9% | 3,058 | 0.0% | 0.07% | -1.4% |
Q2 2023 | $308,611 | +6.5% | 3,058 | -2.9% | 0.07% | -6.4% |
Q1 2023 | $289,826 | +0.2% | 3,150 | -1.2% | 0.08% | -6.0% |
Q4 2022 | $289,331 | +20.6% | 3,189 | +1.2% | 0.08% | +7.8% |
Q3 2022 | $240,000 | -10.8% | 3,150 | -1.1% | 0.08% | -6.1% |
Q2 2022 | $269,000 | -3.6% | 3,185 | +0.3% | 0.08% | +9.3% |
Q1 2022 | $279,000 | +3.3% | 3,175 | +2.9% | 0.08% | +11.9% |
Q4 2021 | $270,000 | -11.8% | 3,086 | -17.3% | 0.07% | -25.6% |
Q3 2021 | $306,000 | -9.7% | 3,733 | +0.6% | 0.09% | -8.2% |
Q2 2021 | $339,000 | +11.1% | 3,709 | +3.9% | 0.10% | +6.5% |
Q1 2021 | $305,000 | -13.4% | 3,571 | -4.0% | 0.09% | -16.4% |
Q4 2020 | $352,000 | +12.8% | 3,719 | +3.6% | 0.11% | +0.9% |
Q3 2020 | $312,000 | -29.1% | 3,589 | -28.6% | 0.11% | -24.3% |
Q2 2020 | $440,000 | +5.0% | 5,029 | -1.1% | 0.14% | -9.4% |
Q1 2020 | $419,000 | -18.0% | 5,085 | -5.8% | 0.16% | +6.7% |
Q4 2019 | $511,000 | +10.1% | 5,398 | +1.1% | 0.15% | -0.7% |
Q3 2019 | $464,000 | -2.9% | 5,340 | +1.9% | 0.15% | -3.2% |
Q2 2019 | $478,000 | -6.1% | 5,240 | -1.1% | 0.16% | -9.9% |
Q1 2019 | $509,000 | +12.1% | 5,299 | +0.1% | 0.17% | +6.2% |
Q4 2018 | $454,000 | -3.0% | 5,293 | -2.5% | 0.16% | 0.0% |
Q3 2018 | $468,000 | +33.0% | 5,428 | +16.4% | 0.16% | +23.7% |
Q2 2018 | $352,000 | -7.6% | 4,665 | -0.9% | 0.13% | -9.7% |
Q1 2018 | $381,000 | -6.2% | 4,706 | -2.7% | 0.14% | -2.0% |
Q4 2017 | $406,000 | +5.7% | 4,836 | +7.9% | 0.15% | -1.3% |
Q3 2017 | $384,000 | +2.4% | 4,482 | -0.2% | 0.15% | -2.6% |
Q2 2017 | $375,000 | +13.3% | 4,492 | +0.7% | 0.15% | +8.5% |
Q1 2017 | $331,000 | -8.6% | 4,461 | -10.3% | 0.14% | -10.7% |
Q4 2016 | $362,000 | +306.7% | 4,974 | +340.6% | 0.16% | +287.8% |
Q3 2016 | $89,000 | -8.2% | 1,129 | -3.9% | 0.04% | -12.8% |
Q2 2016 | $97,000 | +14.1% | 1,175 | 0.0% | 0.05% | +9.3% |
Q1 2016 | $85,000 | -15.8% | 1,175 | 0.0% | 0.04% | -14.0% |
Q4 2015 | $101,000 | -6.5% | 1,175 | 0.0% | 0.05% | -18.0% |
Q3 2015 | $108,000 | -58.6% | 1,175 | -61.7% | 0.06% | -62.8% |
Q1 2014 | $261,000 | -7.4% | 3,071 | -12.8% | 0.16% | -14.1% |
Q4 2013 | $282,000 | +15.6% | 3,521 | +10.9% | 0.19% | +0.5% |
Q3 2013 | $244,000 | +8.4% | 3,175 | 0.0% | 0.19% | +6.7% |
Q2 2013 | $225,000 | – | 3,175 | – | 0.18% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GODSEY & GIBB, INC | 184,900 | $15,121,000 | 6.74% |
Martin Investment Management, LLC | 289,924 | $23,710,000 | 5.98% |
Camber Capital Management LP | 2,000,000 | $163,560,000 | 5.04% |
MANAGED ASSET PORTFOLIOS, LLC | 381,778 | $31,222,000 | 4.76% |
PROFESSIONAL ADVISORY SERVICES INC | 267,779 | $21,899,000 | 3.22% |
SCHARF INVESTMENTS, LLC | 1,244,711 | $101,794,000 | 3.21% |
GARLAND CAPITAL MANAGEMENT INC | 50,755 | $4,151,000 | 2.97% |
First Fiduciary Investment Counsel, Inc. | 167,378 | $13,688,000 | 2.67% |
WILKINS INVESTMENT COUNSEL INC | 130,590 | $10,680,000 | 2.61% |
Lowell Blake & Associates Inc. | 66,309 | $5,423,000 | 2.52% |